Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Network pharmacology-based identification of key pharmacological pathways of Yin–Huang–Qing–Fei capsule acting on chronic bronchitis

1 Dec 2016

Abstract excerpt

For decades in China, the Yin-Huang-Qing-Fei capsule (YHQFC) has been widely used in the treatment of chronic bronchitis, with good curative effects. Owing to the complexity of traditional Chinese herbal formulas, the pharmacological mechanism of YHQFC remains unclear. To address this problem, a network pharmacology-based strategy was proposed in this study. At first, the putative target profile of YHQFC was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Asthma and respiratory diseases
Share to Computational Drug Discovery Methods

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28053519
DOI: 10.2147/copd.s121079

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Network pharmacology-based identification of key pharmacological pathways of Yin–Huang–Qing–Fei capsule acting on chronic bronchitisPMID 28053519Read ↗

Exploring the Comorbidity Mechanisms Between Asthma and Idiopathic Pulmonary Fibrosis and the Pharmacological Mechanisms of Bu-Shen-Yi-Qi Decoction Therapy via Network PharmacologySemantic proximity Read ↗

Integrative network pharmacology and molecular docking to reveal the mechanism of Jinqiaomai tablet on asthmaSemantic proximity Read ↗

Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacologySemantic proximity Read ↗

Investigation of Anti-Epithelial-Mesenchymal Transition and Anti-Inflammation effects of Qing Fei Hua Xian Decotion on Pulmonary Fibrosis via Network Pharmacology and Experimental VerificationSemantic proximity Read ↗

Exploring the Anti-Pulmonary Fibrosis Mechanism of Jingyin Granule by Network Pharmacology StrategySemantic proximity Read ↗

Identification of the active compounds and pharmacological mechanisms of Xiaoqinglong decoction for asthma based on network pharmacology and molecular docking technologySemantic proximity Read ↗

Exploration of the Mechanism of Shengxian Decoction Against Chronic Obstructive Pulmonary Disease Based on Network Pharmacology and Experimental VerificationSemantic proximity Read ↗

Molecular mechanism of the anti-lung cancer effect of Jin Ning Fang based on network pharmacology and experimental verificationSemantic proximity Read ↗

Network pharmacology-based mechanistic investigation of Jinshui Huanxian formula acing on idiopathic pulmonary fibrosisSemantic proximity Read ↗

Anti-inflammatory Properties of Fangji Huangqi Tang: Discovery Based on Network Pharmacology, Molecular Docking and Arrowsmith ToolsSemantic proximity Read ↗

Exploration of Fuzheng Yugan Mixture on COVID-19 based on network pharmacology and molecular dockingSemantic proximity Read ↗

Network pharmacology combined with metabolomics to explore the mechanism for Lonicerae Japonicae flos against respiratory syncytial virusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.